Contemporary management of cardiovascular implantable electronic device infections

References

• Epstein AE, DiMarco JP, Ellenbogen KA et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J. Am. Coll. Cardiol.51(21), e1–e62 (2008).
   PubMedGoogle Scholar
• Sohail MR, Wilson WR, Baddour LM. Infections of nonvalvular cardiovascular devices. In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. Mandell GL, Bennett JE, Dolin R (Eds). Churchill Livingstone/Elsevier, PA, USA, 1127–1142 (2010).
   Google Scholar
• Baddour LM, Epstein AE, Erickson CC et al. Update on cardiovascular implantable electronic device infections and their management. A scientific statement from the American Heart Association. Circulation121(3), 458–477 (2010).
   PubMed Web of Science ®Google Scholar
• Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J. Am. Coll. Cardiol.48(3), 590–591 (2006).
   PubMed Web of Science ®Google Scholar
• Cabell CH, Heidenreich PA, Chu VH et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990–1999. Am. Heart J.147(4), 582–586 (2004).
   PubMed Web of Science ®Google Scholar
• Cacoub P, Leprince P, Nataf P et al. Pacemaker infective endocarditis. Am. J. Cardiol.82(4), 480–484 (1998).
   PubMed Web of Science ®Google Scholar
• Sohail MR, Uslan DZ, Khan AH et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J. Am. Coll. Cardiol.49(18), 1851–1859 (2007).
   PubMed Web of Science ®Google Scholar
• Sohail MR, Uslan DZ, Khan AH et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin. Proc.83(1), 46–53 (2008).
   PubMed Web of Science ®Google Scholar
• Darouiche RO. Treatment of infections associated with surgical implants. N. Engl. J. Med.350(14), 1422–1429 (2004).
   PubMed Web of Science ®Google Scholar
• Lai KK, Fontecchio SA. Infections associated with implantable cardioverter defibrillators placed transvenously and via thoracotomies: epidemiology, infection control, and management. Clin. Infect. Dis.27(2), 265–269 (1998).
   PubMed Web of Science ®Google Scholar
• Trappe HJ, Pfitzner P, Klein H, Wenzlaff P. Infections after cardioverter-defibrillator implantation: observations in 335 patients over 10 years. Br. Heart J.73(1), 20–24 (1995).
   PubMedGoogle Scholar
• Mela T, McGovern BA, Garan H et al. Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter-defibrillator implants. Am. J. Cardiol.88(7), 750–753 (2001).
   PubMed Web of Science ®Google Scholar
• Klug D, Balde M, Pavin D et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation116(12), 1349–1355 (2007).
   PubMed Web of Science ®Google Scholar
• Sohail MR, Uslan DZ, Khan AH et al. Risk factor analysis of permanent pacemaker infection. Clin. Infect. Dis.45(2), 166–173 (2007).
   PubMed Web of Science ®Google Scholar
• Lekkerkerker JC, van Nieuwkoop C, Trines SA et al. Risk factors and time delay associated with cardiac device infections: Leiden device registry. Heart95(9), 715–720 (2009).
   PubMed Web of Science ®Google Scholar
• Bloom H, Heeke B, Leon A et al. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin. Electrophysiol.29(2), 142–145 (2006).
   PubMed Web of Science ®Google Scholar
• Da Costa A, Lelievre H, Kirkorian G et al. Role of the preaxillary flora in pacemaker infections: a prospective study. Circulation97(18), 1791–1795 (1998).
   PubMed Web of Science ®Google Scholar
• Le KY, Sohail MR, Friedman PA et al. Clinical predictors of cardiovascular implantable electronic device-related infective endocarditis. Presented at: Annual Infectious Diseases Society of America (IDSA) meeting. Philadelphia, PA, USA, 29 October–1 November 2009.
   Google Scholar
• Uslan DZ, Dowsley TF, Sohail MR et al. Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia. Pacing Clin. Electrophysiol.33(4), 407–413 (2009).
   PubMedGoogle Scholar
• Uslan DZ, Sohail MR, Friedman PA et al. Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with Gram-negative bacteremia. Clin. Infect. Dis.43(6), 731–736 (2006).
   PubMed Web of Science ®Google Scholar
• Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann. Intern. Med.133(8), 604–608 (2000).
   PubMed Web of Science ®Google Scholar
• Dy Chua J, Abdul-Karim A, Mawhorter S et al. The role of swab and tissue culture in the diagnosis of implantable cardiac device infection. Pacing Clin. Electrophysiol.28(12), 1276–1281 (2005).
   PubMed Web of Science ®Google Scholar
• Sohail MR. Concerning diagnosis and management of pacemaker endocarditis. Pacing Clin. Electrophysiol.30(6), 829; author reply 830 (2007).
   PubMedGoogle Scholar
• Uslan DZ, Crane SJ, Steckelberg JM et al. Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch. Intern. Med.167(8), 834–839 (2007).
   PubMedGoogle Scholar
• Chamis AL, Peterson GE, Cabell CH et al.Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation104(9), 1029–1033 (2001).
   PubMed Web of Science ®Google Scholar
• Kennergren C, Bjurman C, Wiklund R, Gabel J. A single-centre experience of over one thousand lead extractions. Europace11(5), 612–617 (2009).
   PubMed Web of Science ®Google Scholar
• de Oliveira JC, Martinelli M, Nishioka SA et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ. Arrhythm. Electrophysiol.2(1), 29–34 (2009).
   PubMed Web of Science ®Google Scholar
• Da Costa A, Kirkorian G, Cucherat M et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation97(18), 1796–1801 (1998).
   PubMed Web of Science ®Google Scholar
• Bode LGM, Kluytmans JAJW, Wertheim HFL et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus.N. Engl. J. Med.362(1), 9–17 (2010).
   PubMed Web of Science ®Google Scholar
• Darouiche RO, Wall MJ Jr, Itani KMF et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N. Engl. J. Med.362(1), 18–26 (2010).
   PubMed Web of Science ®Google Scholar
• Steckelberg JM, Wilson WR. Infections associated with implantable cardioverter defibrillators – still more questions. Clin. Infect. Dis.27(2), 270–271 (1998).
   PubMedGoogle Scholar
• Mermel LA, Allon M, Bouza E et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis.49(1), 1–45 (2009).
   PubMed Web of Science ®Google Scholar
• Uslan DZ, Sohail MR, St Sauver JL et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch. Intern. Med.167(7), 669–675 (2007).
   PubMed Web of Science ®Google Scholar